Replimune Group, Inc.
REPLNASDAQHealthcare● Active
$8.97
$-0.50(-5.28%)
Market Cap$740676392
P/E Ratio—
52W High$13.24
52W Low$1.5
Replimune Group, Inc.（REPL）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · REPL · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.25B) | ($0.22B) | ($0.17B) | ($0.12B) | ($0.08B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.04B | $0.03B | $0.03B | $0.02B | $0.01B |
| Change in Working Capital | $0.02B | $0.01B | $0.02B | $0.01B | $0.00B |
| Net Cash from Operations | ($0.19B) | ($0.19B) | ($0.13B) | ($0.08B) | ($0.06B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.40B) | ($0.49B) | ($0.58B) | ($0.26B) | ($0.39B) |
| Sales of Investments | $0.39B | $0.59B | $0.44B | $0.26B | $0.21B |
| Net Cash from Investing | ($0.02B) | $0.10B | ($0.14B) | ($0.00B) | ($0.19B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | $0.01B | $0.03B | ($0.00B) | ($0.01B) |
| Net Cash from Financing | $0.25B | $0.02B | $0.31B | $0.01B | $0.37B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.20B) | ($0.19B) | ($0.13B) | ($0.08B) | ($0.06B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Replimune Group, Inc.
关于Replimune Group, Inc.（REPL）现金流量表
Replimune Group, Inc. 2025财年经营活动现金流($0.19B)，自由现金流($0.20B)（FCF利润率—），资本支出($0.01B)。
常见问题
REPL · 4 问Replimune Group, Inc. 2025财年自由现金流($0.20B)，同比down4.1%。
REPL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10